These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24911474)

  • 21. Exploring the Case for Eminent Domain of Hepatitis C Virus Treatment Patents.
    Mattingly Ii TJ; Heil EL; Hoke KS
    J Health Care Poor Underserved; 2017; 28(2):621-625. PubMed ID: 28529212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sofosbuvir for the treatment of hepatitis C virus infection.
    Rolland S; Vachon ML
    CMAJ; 2015 Feb; 187(3):203-204. PubMed ID: 25002563
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmaceuticals. Advocates protest the cost of a hepatitis C cure.
    Cohen J
    Science; 2013 Dec; 342(6164):1302-3. PubMed ID: 24337268
    [No Abstract]   [Full Text] [Related]  

  • 24. [Is more expensive always better?].
    Drenth JP
    Ned Tijdschr Geneeskd; 2014; 159():A8556. PubMed ID: 25534272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The uses and abuses of cost-effectiveness analysis.
    Goozner M
    Mod Healthc; 2014 Aug; 44(32):26. PubMed ID: 25318245
    [No Abstract]   [Full Text] [Related]  

  • 26. Editorial: patients' preferences and health utility assessment in those with HCV treated with sofosbuvir - stating the obvious?
    Lim SG; Gandhi M; Chan E
    Aliment Pharmacol Ther; 2014 Nov; 40(9):1115. PubMed ID: 25280256
    [No Abstract]   [Full Text] [Related]  

  • 27. [Not Available].
    Springer Medizin
    MMW Fortschr Med; 2016 Jul; 158(13):10-1. PubMed ID: 27439800
    [No Abstract]   [Full Text] [Related]  

  • 28. Campaigners challenge patent applications for hepatitis C drug in five countries.
    Bagcchi S
    BMJ; 2015 Jun; 350():h2938. PubMed ID: 26032985
    [No Abstract]   [Full Text] [Related]  

  • 29. Patent battle lines drawn as sofosbuvir gains approval.
    Harrison C
    Nat Rev Drug Discov; 2014 Jan; 13(1):12. PubMed ID: 24378791
    [No Abstract]   [Full Text] [Related]  

  • 30. New drugs: simeprevir, sofosbuvir, and dolutegravir sodium.
    Hussar DA; Jin ZJ
    J Am Pharm Assoc (2003); 2014; 54(2):202-7. PubMed ID: 24632934
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatitis C drugs not reaching poor.
    Callaway E
    Nature; 2014 Apr; 508(7496):295-6. PubMed ID: 24740042
    [No Abstract]   [Full Text] [Related]  

  • 32. Economic and Public Health Impacts of Policies Restricting Access to Hepatitis C Treatment for Medicaid Patients.
    Chidi AP; Bryce CL; Donohue JM; Fine MJ; Landsittel DP; Myaskovsky L; Rogal SS; Switzer GE; Tsung A; Smith KJ
    Value Health; 2016 Jun; 19(4):326-34. PubMed ID: 27325324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutant Ninja viruses.
    Foster GR
    Hepatology; 2015 Feb; 61(2):421-3. PubMed ID: 25266372
    [No Abstract]   [Full Text] [Related]  

  • 34. New Hepatitis C Drugs Are Very Costly And Unavailable To Many State Prisoners.
    Beckman AL; Bilinski A; Boyko R; Camp GM; Wall AT; Lim JK; Wang EA; Bruce RD; Gonsalves GS
    Health Aff (Millwood); 2016 Oct; 35(10):1893-1901. PubMed ID: 27702964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Why Sovaldi shouldn't cost $84,000.
    Goozner M
    Mod Healthc; 2014 May; 44(18):26. PubMed ID: 25033627
    [No Abstract]   [Full Text] [Related]  

  • 36. HIV-hepatitis C co-infection.
    Hayward P
    Lancet Infect Dis; 2015 Apr; 15(4):382. PubMed ID: 25809897
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug pricing: still a barrier to elimination of HCV.
    The Lancet Gastroenterology Hepatology
    Lancet Gastroenterol Hepatol; 2018 Dec; 3(12):813. PubMed ID: 30507462
    [No Abstract]   [Full Text] [Related]  

  • 38. Early Patterns of Sofosbuvir Utilization by State Medicaid Programs.
    Liao JM; Fischer MA
    N Engl J Med; 2015 Sep; 373(13):1279-81. PubMed ID: 26398092
    [No Abstract]   [Full Text] [Related]  

  • 39. Sovaldi ushers in wave of costly hepatitis C drugs.
    Manag Care; 2014 Jan; 23(1):51. PubMed ID: 24765752
    [No Abstract]   [Full Text] [Related]  

  • 40. Sofosbuvir (Sovaldi) for chronic hepatitis C.
    Med Lett Drugs Ther; 2014 Jan; 56(1434):5-6. PubMed ID: 24457562
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.